PMID- 10521481 OWN - NLM STAT- MEDLINE DCOM- 19991123 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 274 IP - 43 DP - 1999 Oct 22 TI - Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2- and p38 mitogen-activated protein kinase-dependent TNF-alpha gene expression. PG - 30882-6 AB - Engagement of the tumor necrosis factor-alpha (TNF-alpha) receptors by the TNF-alpha ligand results in the rapid induction of TNF-alpha gene expression. The study presented here shows that autoregulation of TNF-alpha gene transcription by selective signaling through tumor necrosis factor receptor 1 (TNFR1) requires p38 mitogen-activated protein (MAP) kinase activity and the binding of the transcription factors ATF-2 and Jun to the TNF-alpha cAMP-response element (CRE) promoter element. Consistent with these findings, TNFR1 engagement results in increased p38 MAP kinase activity and p38-dependent phosphorylation of ATF-2. Furthermore, overexpression of MADD (MAP kinase-activating death domain protein), an adapter protein that binds to the death domain of TNFR1 and activates MAP kinase cascades, results in CRE-dependent induction of TNF-alpha gene expression. Thus, the TNF-alpha CRE site is the target of TNFR1 stimulation and mediates the autoregulation of TNF-alpha gene transcription. FAU - Brinkman, B M AU - Brinkman BM AD - Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA. FAU - Telliez, J B AU - Telliez JB FAU - Schievella, A R AU - Schievella AR FAU - Lin, L L AU - Lin LL FAU - Goldfeld, A E AU - Goldfeld AE LA - eng GR - CA58735/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (ATF2 protein, human) RN - 0 (Activating Transcription Factor 2) RN - 0 (Antigens, CD) RN - 0 (Atf2 protein, mouse) RN - 0 (Carrier Proteins) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Death Domain Receptor Signaling Adaptor Proteins) RN - 0 (Guanine Nucleotide Exchange Factors) RN - 0 (MADD protein, human) RN - 0 (Madd protein, mouse) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Receptors, Tumor Necrosis Factor, Type I) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Activating Transcription Factor 2 MH - Animals MH - Antigens, CD/*physiology MH - Base Sequence MH - Binding Sites MH - Carrier Proteins/genetics/metabolism MH - Cyclic AMP Response Element-Binding Protein/*metabolism MH - Death Domain Receptor Signaling Adaptor Proteins MH - *Gene Expression Regulation MH - Genes, Reporter MH - *Guanine Nucleotide Exchange Factors MH - Humans MH - L Cells MH - Leucine Zippers MH - Mice MH - Mitogen-Activated Protein Kinases/metabolism MH - Promoter Regions, Genetic MH - Receptors, Tumor Necrosis Factor/*physiology MH - Receptors, Tumor Necrosis Factor, Type I MH - Recombinant Fusion Proteins/biosynthesis MH - Signal Transduction MH - Transcription Factors/*metabolism MH - Transfection MH - Tumor Necrosis Factor-alpha/*genetics MH - p38 Mitogen-Activated Protein Kinases EDAT- 1999/10/16 00:00 MHDA- 1999/10/16 00:01 CRDT- 1999/10/16 00:00 PHST- 1999/10/16 00:00 [pubmed] PHST- 1999/10/16 00:01 [medline] PHST- 1999/10/16 00:00 [entrez] AID - 10.1074/jbc.274.43.30882 [doi] AID - S0021-9258(19)51761-6 [pii] PST - ppublish SO - J Biol Chem. 1999 Oct 22;274(43):30882-6. doi: 10.1074/jbc.274.43.30882.